ID   SPSY_HUMAN              Reviewed;         366 AA.
AC   P52788; A6NHA7; A6NI34; B2R9M0; O00544; Q9UQS1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Spermine synthase;
DE            Short=SPMSY;
DE            EC=2.5.1.22;
DE   AltName: Full=Spermidine aminopropyltransferase;
GN   Name=SMS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7546290; DOI=10.1089/dna.1995.14.841;
RA   Korhonen V.-P., Halmekytoe M., Kauppinen L., Myoehaenen S.,
RA   Wahlfors J., Keinaenen T., Hyvoenen T., Alhonen L., Eloranta T.,
RA   Jaenne J.;
RT   "Molecular cloning of a cDNA encoding human spermine synthase.";
RL   DNA Cell Biol. 14:841-847(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=9299240; DOI=10.1006/geno.1997.4876;
RA   Grieff M., Whyte M.P., Thakker R.V., Mazzarella R.;
RT   "Sequence analysis of 139 kb in Xp22.1 containing spermine synthase
RT   and the 5' region of PEX.";
RL   Genomics 44:227-231(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE.
RA   Eloranta T., Kajander O., Kauppinen L., Hyvoenen T.,
RA   Linnala-Kankkunen A., Kalkkinen N., Kulomaa M., Alhonen L., Jaenne J.;
RL   (In) Goldemberg S.H., Algranati I.D. (eds.);
RL   Proceedings of the international symposium on the biology and
RL   chemistry of polyamines, pp.91-98, ICSU Press, New York (1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 97-107 (ISOFORM 1).
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   INVOLVEMENT IN MRXSSR.
RX   PubMed=14508504; DOI=10.1038/sj.ejhg.5201072;
RA   Cason A.L., Ikeguchi Y., Skinner C., Wood T.C., Holden K.R.,
RA   Lubs H.A., Martinez F., Simensen R.J., Stevenson R.E., Pegg A.E.,
RA   Schwartz C.E.;
RT   "X-linked spermine synthase gene (SMS) defect: the first polyamine
RT   deficiency syndrome.";
RL   Eur. J. Hum. Genet. 11:937-944(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 5-366 (ISOFORM 1) IN COMPLEX
RP   WITH SPERMIDINE AND 5-METHYLTHIOADENOSINE, SUBUNIT, AND MUTAGENESIS OF
RP   ASP-201; ASP-276 AND GLU-353.
RX   PubMed=18367445; DOI=10.1074/jbc.M710323200;
RA   Wu H., Min J., Zeng H., McCloskey D.E., Ikeguchi Y., Loppnau P.,
RA   Michael A.J., Pegg A.E., Plotnikov A.N.;
RT   "Crystal structure of human spermine synthase: implications of
RT   substrate binding and catalytic mechanism.";
RL   J. Biol. Chem. 283:16135-16146(2008).
RN   [15]
RP   VARIANT MRXSSR SER-56, INVOLVEMENT IN MRXSSR, AND CHARACTERIZATION OF
RP   VARIANT MRXSSR SER-56.
RX   PubMed=18550699; DOI=10.1136/jmg.2007.056713;
RA   de Alencastro G., McCloskey D.E., Kliemann S.E., Maranduba C.M.,
RA   Pegg A.E., Wang X., Bertola D.R., Schwartz C.E., Passos-Bueno M.R.,
RA   Sertie A.L.;
RT   "New SMS mutation leads to a striking reduction in spermine synthase
RT   protein function and a severe form of Snyder-Robinson X-linked
RT   recessive mental retardation syndrome.";
RL   J. Med. Genet. 45:539-543(2008).
RN   [16]
RP   VARIANT MRXSSR GLY-132, AND INVOLVEMENT IN MRXSSR.
RX   PubMed=19206178; DOI=10.1002/ajmg.a.32641;
RA   Becerra-Solano L.E., Butler J., Castaneda-Cisneros G., McCloskey D.E.,
RA   Wang X., Pegg A.E., Schwartz C.E., Sanchez-Corona J.,
RA   Garcia-Ortiz J.E.;
RT   "A missense mutation, p.V132G, in the X-linked spermine synthase gene
RT   (SMS) causes Snyder-Robinson syndrome.";
RL   Am. J. Med. Genet. A 149A:328-335(2009).
RN   [17]
RP   VARIANT MRXSSR LEU-58.
RX   PubMed=22612257; DOI=10.1111/j.1528-1167.2012.03516.x;
RA   Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C.,
RA   Steiner I., Hansen J., Courage C., Gallati S., Buerki S., Strozzi S.,
RA   Simonetti B.G., Grunt S., Steinlin M., Alber M., Wolff M.,
RA   Klopstock T., Prott E.C., Lorenz R., Spaich C., Rona S.,
RA   Lakshminarasimhan M., Kroell J., Dorn T., Kraemer G., Synofzik M.,
RA   Becker F., Weber Y.G., Lerche H., Boehm D., Biskup S.;
RT   "Targeted next generation sequencing as a diagnostic tool in epileptic
RT   disorders.";
RL   Epilepsia 53:1387-1398(2012).
RN   [18]
RP   VARIANT MRXSSR GLU-67, AND CHARACTERIZATION OF VARIANT MRXSSR GLU-67.
RX   PubMed=23897707; DOI=10.1002/ajmg.a.36116;
RA   Peron A., Spaccini L., Norris J., Bova S.M., Selicorni A., Weber G.,
RA   Wood T., Schwartz C.E., Mastrangelo M.;
RT   "Snyder-Robinson syndrome: a novel nonsense mutation in spermine
RT   synthase and expansion of the phenotype.";
RL   Am. J. Med. Genet. A 161A:2316-2320(2013).
RN   [19]
RP   ERRATUM.
RA   Peron A., Spaccini L., Norris J., Bova S.M., Selicorni A., Weber G.,
RA   Wood T., Schwartz C.E., Mastrangelo M.;
RL   Am. J. Med. Genet. A 161A:1083-1083(2014).
RN   [20]
RP   VARIANT MRXSSR CYS-328, AND CHARACTERIZATION OF VARIANT MRXSSR
RP   CYS-328.
RX   PubMed=23696453; DOI=10.1093/hmg/ddt229;
RA   Zhang Z., Norris J., Kalscheuer V., Wood T., Wang L., Schwartz C.,
RA   Alexov E., Van Esch H.;
RT   "A Y328C missense mutation in spermine synthase causes a mild form of
RT   Snyder-Robinson syndrome.";
RL   Hum. Mol. Genet. 22:3789-3797(2013).
RN   [21]
RP   VARIANT SER-60.
RX   PubMed=24680889; DOI=10.1016/j.ajhg.2014.03.006;
RG   UK10K Consortium;
RA   Grozeva D., Carss K., Spasic-Boskovic O., Parker M.J., Archer H.,
RA   Firth H.V., Park S.M., Canham N., Holder S.E., Wilson M., Hackett A.,
RA   Field M., Floyd J.A., Hurles M., Raymond F.L.;
RT   "De novo loss-of-function mutations in SETD5, encoding a
RT   methyltransferase in a 3p25 microdeletion syndrome critical region,
RT   cause intellectual disability.";
RL   Am. J. Hum. Genet. 94:618-624(2014).
CC   -!- FUNCTION: Catalyzes the production of spermine from spermidine and
CC       decarboxylated S-adenosylmethionine (dcSAM).
CC   -!- CATALYTIC ACTIVITY: S-adenosyl 3-(methylthio)propylamine +
CC       spermidine = S-methyl-5'-thioadenosine + spermine.
CC   -!- PATHWAY: Amine and polyamine biosynthesis; spermine biosynthesis;
CC       spermine from spermidine: step 1/1.
CC   -!- SUBUNIT: Homodimer. Dimerization is mediated through the N-
CC       terminal domain and seems to be required for activity as deletion
CC       of the N-terminal domain causes complete loss of activity.
CC       {ECO:0000269|PubMed:18367445}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P52788-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P52788-2; Sequence=VSP_034406;
CC         Note=Gene prediction confirmed by EST data.;
CC   -!- DOMAIN: Composed of 3 domains: the N-terminal domain has
CC       structural similarity to S-adenosylmethionine decarboxylase, the
CC       central domain is made up of four beta strands and the C-terminal
CC       domain is similar in structure to spermidine synthase. The N- and
CC       C-terminal domains are both required for activity.
CC   -!- DISEASE: X-linked syndromic mental retardation Snyder-Robinson
CC       type (MRXSSR) [MIM:309583]: Characterized by moderate intellectual
CC       deficit, hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis
CC       and facial asymmetry. Transmission is X-linked recessive.
CC       {ECO:0000269|PubMed:14508504, ECO:0000269|PubMed:18550699,
CC       ECO:0000269|PubMed:19206178, ECO:0000269|PubMed:22612257,
CC       ECO:0000269|PubMed:23696453, ECO:0000269|PubMed:23897707}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the spermidine/spermine synthase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z49099; CAA88921.1; -; mRNA.
DR   EMBL; AD001528; AAB61308.1; -; mRNA.
DR   EMBL; AK313834; BAG36567.1; -; mRNA.
DR   EMBL; U53331; AAD08634.1; -; Genomic_DNA.
DR   EMBL; U73023; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471074; EAW98984.1; -; Genomic_DNA.
DR   EMBL; BC009898; AAH09898.1; -; mRNA.
DR   EMBL; BC085621; AAH85621.1; -; mRNA.
DR   CCDS; CCDS14203.1; -. [P52788-1]
DR   CCDS; CCDS59161.1; -. [P52788-2]
DR   PIR; S54160; S54160.
DR   RefSeq; NP_001245352.1; NM_001258423.1. [P52788-2]
DR   RefSeq; NP_004586.2; NM_004595.4. [P52788-1]
DR   UniGene; Hs.724874; -.
DR   PDB; 3C6K; X-ray; 1.95 A; A/B/C/D=5-366.
DR   PDB; 3C6M; X-ray; 2.45 A; A/B/C/D=5-366.
DR   PDBsum; 3C6K; -.
DR   PDBsum; 3C6M; -.
DR   ProteinModelPortal; P52788; -.
DR   SMR; P52788; -.
DR   BioGrid; 112495; 44.
DR   IntAct; P52788; 17.
DR   MINT; MINT-5002620; -.
DR   STRING; 9606.ENSP00000385746; -.
DR   BindingDB; P52788; -.
DR   ChEMBL; CHEMBL4934; -.
DR   DrugBank; DB00127; Spermine.
DR   iPTMnet; P52788; -.
DR   PhosphoSitePlus; P52788; -.
DR   BioMuta; SMS; -.
DR   DMDM; 8247960; -.
DR   OGP; P52788; -.
DR   EPD; P52788; -.
DR   MaxQB; P52788; -.
DR   PaxDb; P52788; -.
DR   PeptideAtlas; P52788; -.
DR   PRIDE; P52788; -.
DR   DNASU; 6611; -.
DR   Ensembl; ENST00000379404; ENSP00000368714; ENSG00000102172. [P52788-2]
DR   Ensembl; ENST00000404933; ENSP00000385746; ENSG00000102172. [P52788-1]
DR   GeneID; 6611; -.
DR   KEGG; hsa:6611; -.
DR   UCSC; uc004dag.5; human. [P52788-1]
DR   CTD; 6611; -.
DR   DisGeNET; 6611; -.
DR   GeneCards; SMS; -.
DR   GeneReviews; SMS; -.
DR   HGNC; HGNC:11123; SMS.
DR   HPA; HPA029849; -.
DR   HPA; HPA029852; -.
DR   MalaCards; SMS; -.
DR   MIM; 300105; gene.
DR   MIM; 309583; phenotype.
DR   neXtProt; NX_P52788; -.
DR   OpenTargets; ENSG00000102172; -.
DR   Orphanet; 3063; X-linked intellectual disability, Snyder type.
DR   PharmGKB; PA35972; -.
DR   eggNOG; KOG1562; Eukaryota.
DR   eggNOG; COG0421; LUCA.
DR   GeneTree; ENSGT00870000136506; -.
DR   HOGENOM; HOG000007053; -.
DR   HOVERGEN; HBG004512; -.
DR   InParanoid; P52788; -.
DR   KO; K00802; -.
DR   OMA; EGRMFDY; -.
DR   OrthoDB; EOG091G0BXC; -.
DR   PhylomeDB; P52788; -.
DR   TreeFam; TF324508; -.
DR   BioCyc; MetaCyc:HS02362-MONOMER; -.
DR   BRENDA; 2.5.1.22; 2681.
DR   Reactome; R-HSA-351202; Metabolism of polyamines.
DR   SABIO-RK; P52788; -.
DR   UniPathway; UPA00249; UER00315.
DR   EvolutionaryTrace; P52788; -.
DR   GeneWiki; SMS_(gene); -.
DR   GenomeRNAi; 6611; -.
DR   PRO; PR:P52788; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102172; -.
DR   CleanEx; HS_SMS; -.
DR   ExpressionAtlas; P52788; baseline and differential.
DR   Genevisible; P52788; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016768; F:spermine synthase activity; IBA:GO_Central.
DR   GO; GO:0006555; P:methionine metabolic process; TAS:ProtInc.
DR   GO; GO:0006595; P:polyamine metabolic process; TAS:Reactome.
DR   GO; GO:0006597; P:spermine biosynthetic process; IBA:GO_Central.
DR   InterPro; IPR030374; PABS.
DR   InterPro; IPR030373; PABS_CS.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   InterPro; IPR015576; Spermine_synthase_animal.
DR   PANTHER; PTHR11558:SF34; PTHR11558:SF34; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS01330; PABS_1; 1.
DR   PROSITE; PS51006; PABS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Mental retardation; Phosphoprotein;
KW   Polyamine biosynthesis; Polymorphism; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    366       Spermine synthase.
FT                                /FTId=PRO_0000156538.
FT   DOMAIN      122    362       PABS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00354}.
FT   REGION      255    256       S-adenosylmethioninamine binding.
FT   ACT_SITE    276    276       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00354}.
FT   BINDING     148    148       S-adenosylmethioninamine.
FT   BINDING     177    177       Spermidine.
FT   BINDING     201    201       Spermidine.
FT   BINDING     220    220       S-adenosylmethioninamine.
FT   BINDING     351    351       Spermidine.
FT   BINDING     353    353       Spermidine.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      57     57       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      57    109       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_034406.
FT   VARIANT      56     56       G -> S (in MRXSSR; a reduced spermine/
FT                                spermidine ratio is observed in patient
FT                                lymphoblastoid cells consistent with
FT                                impaired spermine biosynthesis;
FT                                dbSNP:rs121434610).
FT                                {ECO:0000269|PubMed:18550699}.
FT                                /FTId=VAR_076449.
FT   VARIANT      58     58       F -> L (in MRXSSR; dbSNP:rs397515549).
FT                                {ECO:0000269|PubMed:22612257}.
FT                                /FTId=VAR_072748.
FT   VARIANT      60     60       N -> S. {ECO:0000269|PubMed:24680889}.
FT                                /FTId=VAR_071048.
FT   VARIANT      67     67       G -> E (in MRXSSR; a reduced spermine/
FT                                spermidine ratio is observed in patient
FT                                lymphoblastoid cells consistent with
FT                                impaired spermine biosynthesis;
FT                                dbSNP:rs397515550).
FT                                {ECO:0000269|PubMed:23897707}.
FT                                /FTId=VAR_076450.
FT   VARIANT     132    132       V -> G (in MRXSSR; dbSNP:rs267607076).
FT                                {ECO:0000269|PubMed:19206178}.
FT                                /FTId=VAR_076451.
FT   VARIANT     328    328       Y -> C (in MRXSSR; mild disease
FT                                phenotype; a reduced spermine/spermidine
FT                                ratio is observed in patient
FT                                lymphoblastoid cells consistent with
FT                                impaired spermine biosynthesis;
FT                                dbSNP:rs397515553).
FT                                {ECO:0000269|PubMed:23696453}.
FT                                /FTId=VAR_076452.
FT   MUTAGEN     201    201       D->A,N: 100,000-fold decrease in
FT                                catalytic efficiency.
FT                                {ECO:0000269|PubMed:18367445}.
FT   MUTAGEN     276    276       D->N: 200,000-fold decrease in catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:18367445}.
FT   MUTAGEN     353    353       E->Q: 800-fold decrease in catalytic
FT                                efficiency.
FT                                {ECO:0000269|PubMed:18367445}.
FT   CONFLICT      1      1       M -> MPG (in Ref. 1; CAA88921).
FT                                {ECO:0000305}.
FT   STRAND        5     12       {ECO:0000244|PDB:3C6K}.
FT   HELIX        21     32       {ECO:0000244|PDB:3C6K}.
FT   STRAND       36     42       {ECO:0000244|PDB:3C6K}.
FT   TURN         43     45       {ECO:0000244|PDB:3C6K}.
FT   STRAND       46     52       {ECO:0000244|PDB:3C6K}.
FT   STRAND       58     63       {ECO:0000244|PDB:3C6K}.
FT   STRAND       67     75       {ECO:0000244|PDB:3C6K}.
FT   HELIX        85     98       {ECO:0000244|PDB:3C6K}.
FT   STRAND      114    117       {ECO:0000244|PDB:3C6K}.
FT   STRAND      136    144       {ECO:0000244|PDB:3C6K}.
FT   STRAND      149    155       {ECO:0000244|PDB:3C6K}.
FT   TURN        156    158       {ECO:0000244|PDB:3C6K}.
FT   STRAND      159    164       {ECO:0000244|PDB:3C6K}.
FT   STRAND      167    171       {ECO:0000244|PDB:3C6K}.
FT   HELIX       175    181       {ECO:0000244|PDB:3C6K}.
FT   TURN        182    185       {ECO:0000244|PDB:3C6K}.
FT   STRAND      193    198       {ECO:0000244|PDB:3C6K}.
FT   HELIX       203    209       {ECO:0000244|PDB:3C6K}.
FT   STRAND      214    221       {ECO:0000244|PDB:3C6K}.
FT   HELIX       223    232       {ECO:0000244|PDB:3C6K}.
FT   HELIX       234    237       {ECO:0000244|PDB:3C6M}.
FT   STRAND      242    246       {ECO:0000244|PDB:3C6K}.
FT   STRAND      249    254       {ECO:0000244|PDB:3C6K}.
FT   HELIX       256    266       {ECO:0000244|PDB:3C6K}.
FT   STRAND      270    276       {ECO:0000244|PDB:3C6K}.
FT   HELIX       291    304       {ECO:0000244|PDB:3C6K}.
FT   STRAND      306    318       {ECO:0000244|PDB:3C6K}.
FT   HELIX       322    332       {ECO:0000244|PDB:3C6K}.
FT   STRAND      335    337       {ECO:0000244|PDB:3C6K}.
FT   STRAND      339    346       {ECO:0000244|PDB:3C6K}.
FT   HELIX       349    351       {ECO:0000244|PDB:3C6K}.
FT   STRAND      355    362       {ECO:0000244|PDB:3C6K}.
SQ   SEQUENCE   366 AA;  41268 MW;  D5B23EF61DE66443 CRC64;
     MAAARHSTLD FMLGAKADGE TILKGLQSIF QEQGMAESVH TWQDHGYLAT YTNKNGSFAN
     LRIYPHGLVL LDLQSYDGDA QGKEEIDSIL NKVEERMKEL SQDSTGRVKR LPPIVRGGAI
     DRYWPTADGR LVEYDIDEVV YDEDSPYQNI KILHSKQFGN ILILSGDVNL AESDLAYTRA
     IMGSGKEDYT GKDVLILGGG DGGILCEIVK LKPKMVTMVE IDQMVIDGCK KYMRKTCGDV
     LDNLKGDCYQ VLIEDCIPVL KRYAKEGREF DYVINDLTAV PISTSPEEDS TWEFLRLILD
     LSMKVLKQDG KYFTQGNCVN LTEALSLYEE QLGRLYCPVE FSKEIVCVPS YLELWVFYTV
     WKKAKP
//
